Replies to post #258150 on Amarin Corp Plc (AMRN)

[Bouf]

If they use Covington for the appeal, not a good sign.

They need new fresh eyes and brains on the problem.

Does not seem the Covington handled the experts all that well.

Good news is obviousness is an issue of law that gives the court of appeals some leeway.

[hvypilot]

KOL = ? Key opinion leaders?

[Dancing in the dark]

amarin (for the time being possibly) lost their patent-protected monopoly to sell vascepa without generic competition in the US.

what could amarin do to generics to cause generics to be unprofitable to sell?

mochida epadel is sold over the counter.

no salesforce, just advertising.

[couldbebetter]

JT already put out the press release he will fight at all costs!
JT is ready to gamble all of AMRN's cash that he will be able to
fight and win! Does anyone else see this strategy as being insane?

AMRN should sell to BP (mainly for the value in Europe.) Once BP
own AMRN, they will be in the best position to decide how best to
deal with the generics. JT is too emotionally attached to this
situation so he will not be thinking rationally about what is best
for AMRN shareholders. GIA is a fools errand...and JT seems to
believe this is what he should do. Europe will no doubt have value
to a BP acquirer...but not if JT decides he "needs" to GIA in the
US and make AMRN into a BP...time to look at reality and do something
that will benefit shareholders while you can.